查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1711609

核子醫學/放射性藥物市場分析及預測（至2034年）：類型、產品、服務、技術、應用、最終用戶、形式、材料類型、過程、設備

Nuclear Medicine/Radiopharmaceuticals Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Form, Material Type, Process, Equipment
出版日期: | 出版商: Global Insight Services | 英文 352 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

核子醫學/放射性藥物市場預計將從2024年的48億美元成長到2034年的126億美元，年複合成長率約為 10.1%。該市場涵蓋用於診斷和治療的放射性材料的生產和應用。這些包括 PET 和 SPECT 等診斷影像技術，以及腫瘤學和心臟病學中的治療應用。該市場受到分子成像技術的進步、癌症發病率的上升以及對非侵入性手術的需求不斷成長的推動，凸顯了靶向放射性藥物的創新機會。

市場概覽

核子醫學/放射性藥物市場具有多樣化的特徵，其中診斷放射性藥物佔據市場主導地位，主要是因為它們在疾病的早期發現和管理中發揮關鍵作用。該領域的主導地位可以歸因於癌症和心血管疾病等慢性疾病的盛行率不斷上升，以及 PET 和 SPECT 等影像技術的進步。治療性放射性藥物迅速普及，特別是在腫瘤學領域，而標靶放射性同位素治療提供了一種有前景的治療途徑，且副作用極小。在新興的子區隔中，治療診斷學有望透過整合診斷和治療能力來提供個人化的治療策略，徹底改變市場。此外，放射性藥物在神經病學中的應用日益增多，特別是在阿茲海默症和帕金森氏症的研究中，凸顯了其對市場產生重大影響的潛力。放射性同位素製造領域的持續技術創新和新型放射性藥物的監管支持將進一步推動市場成長，為相關人員創造豐厚的機會。

市場區隔
類型 診斷放射性藥物、治療放射性藥物
產品 Technetium-99m、碘-131、氟-18、鎦-177、釔-90、鎵-68、鐳-223
服務 放射性同位素生產、放射性藥物服務、核子造影服務
技術 單光子發射電腦斷層掃描（SPECT）、正子斷層掃描（PET）、混合影像
目的 腫瘤科、心臟科、神經科、內分泌科、胃腸科、感染疾病科、腎臟科
最終用戶 醫院、診斷影像中心、學術和研究機構
形式 液體、膠囊
材料類型 有機化合物、無機化合物
製造過程 迴旋加速器製造、核子反應爐製造
裝置 伽馬攝影機、PET掃描儀、SPECT掃描儀

在核醫和放射性藥物市場中，由於慢性病的增加以及對早期和精確診斷技術的需求不斷成長，診斷放射性藥物佔據了主要佔有率。治療性放射性藥物也越來越受到關注，反映了標靶癌症治療和個人化醫療方法的進步。北美憑藉其強大的醫療保健基礎設施和大量的研究活動引領市場，而亞太地區則因醫療保健投資的增加和對核醫學應用的認知不斷提高而經歷快速成長。

競爭格局的特點是Siemens Healthineers、GE Healthcare、Cardinal Health等主要企業積極尋求策略聯盟和技術創新，以加強其市場地位。法規環境，尤其是美國和歐洲的監管環境日益嚴格，要求遵守嚴格的安全性和有效性標準。展望未來，由於放射性藥物製造技術的進步以及核醫學在腫瘤學和循環系統的應用不斷擴大，市場預計將經歷顯著成長。然而，儘管新興市場和新的治療應用帶來了巨大的成長機會，但高昂的開發成本和監管核准流程等挑戰仍然存在。

主要趨勢和促進因素：

受診斷影像技術的進步和慢性病盛行率上升的推動，核醫學和放射性藥物市場經歷強勁成長。主要趨勢包括將人工智慧整合到診斷成像解決方案中，以提高診斷的準確性和效率。針對特定疾病的新型放射性藥物的開發也動力強勁，可提供個人化的治療選擇並改善患者的治療效果。

推動市場發展的因素包括對非侵入性診斷技術日益成長的需求以及易患慢性疾病的老年人口的成長。此外，政府推動癌症研究和核子醫學的措施也有助於推動市場擴張。 PET/CT 和 SPECT/CT 等混合影像系統的日益普及也透過提供全面的診斷見解推動了成長。

尚未開發的市場中湧現商業機會，尤其是醫療保健基礎設施發展的新興市場。投資研發生產創新、經濟高效的放射性藥物的公司將佔據有利地位，贏得市場佔有率。此外，學術機構和產業參與者之間的合作推動核醫學的進步，為該領域未來的發展和創新鋪平道路。

限制與挑戰：

核子醫學/放射性藥物市場面臨一些重大的限制和挑戰。首先，嚴格的監管要求帶來重大挑戰。新型放射性藥物的核准過程複雜且漫長，往往延遲進入市場。此外，放射性藥物的高生產成本限制了其可用性和可負擔性，特別是在開發中地區。另一個挑戰是熟練專業人員的短缺。處理和管理放射性藥物所需的專業知識不足，影響了服務的提供。此外，由於放射性藥物的半衰期短，其供應鏈複雜，需要高效率的物流，但這可能難以維持。最後，儘管安全通訊協定取得了進步，但公眾對輻射暴露和安全問題的認知仍然阻礙市場接受。這些挑戰阻礙了核子醫學和放射性藥物的發展和廣泛應用。

目錄

第1章 核醫/放射性藥物市場概述

  • 研究目標
  • 核子醫學/放射性藥物市場定義和範圍
  • 報告限制
  • 調查年份和貨幣
  • 調查方法

第2章 執行摘要

第3章 重要考察

第4章 核子醫學/放射性藥物市場展望

  • 核子醫學/放射性藥物市場細分
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 價值鏈分析
  • 4P模型
  • ANSOFF矩陣

第5章 核子醫學/放射性藥物市場策略

  • 母市場分析
  • 供需分析
  • 消費者購買意向
  • 案例研究分析
  • 定價分析
  • 監管狀況
  • 供應鏈分析
  • 競爭產品分析
  • 近期動態

第6章 核醫/放射性藥物市場規模

  • 核子醫學/放射性藥物市場規模：依金額
  • 核子醫學/放射性藥物市場規模

第7章 核子醫學/放射性藥物市場（依類型）

  • 市場概覽
  • 診斷放射性藥物
  • 治療性放射性藥物
  • 其他

第8章 核子醫學/放射性藥物市場（依產品）

  • 市場概覽
  • Technetium-99m
  • 碘-131
  • 氟-18
  • 鎦-177
  • 釔-90
  • 鎵-68
  • 鐳-223
  • 其他

第9章 核子醫學/放射性藥物市場（依服務）

  • 市場概覽
  • 放射性同位素生產
  • 無線電藥局服務
  • 核子醫學影像服務
  • 其他

第10章 核醫/放射性藥物市場（依技術）

  • 市場概覽
  • 單光子發射電腦斷層掃描（SPECT）
  • 正子斷層掃描（PET）
  • 混合成像
  • 其他

第11章 核醫/放射性藥物市場（依應用）

  • 市場概覽
  • 腫瘤學
  • 循環系統
  • 神經病學
  • 內分泌學
  • 胃腸病學
  • 感染疾病
  • 腎臟病學
  • 其他

第12章 核醫/放射性藥物市場（依最終使用者）

  • 市場概覽
  • 醫院
  • 診斷影像中心
  • 學術和研究機構
  • 其他

第13章 核醫/放射性藥物市場（依形式）

  • 市場概覽
  • 液體
  • 膠囊
  • 其他

第14章 核醫/放射性藥物市場（依材料類型）

  • 市場概覽
  • 有機化合物
  • 無機化合物
  • 其他

第15章 核子醫學/放射性藥物市場（依過程）

  • 市場概覽
  • 迴旋加速器製造
  • 核子反應爐製造
  • 其他

第16章 核醫/放射性藥物市場（依設備）

  • 市場概覽
  • 伽馬攝影機
  • PET掃描儀
  • SPECT掃描儀
  • 其他

第17章 核醫/放射性藥物市場（依地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 瑞典
    • 瑞士
    • 丹麥
    • 芬蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 新加坡
    • 印尼
    • 台灣
    • 馬來西亞
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第18章 競爭格局

  • 概述
  • 市場佔有率分析
  • 主要企業定位
  • 競爭領導地圖
  • 供應商基準化分析
  • 發展策略基準化分析

第19章 公司簡介

  • Advanced Accelerator Applications
  • Jubilant Radiopharma
  • Curium Pharma
  • NorthStar Medical Radioisotopes
  • Shine Medical Technologies
  • Isotopia Molecular Imaging
  • ITM Isotopen Technologien Munchen
  • Eckert & Ziegler
  • Nordion
  • RadioMedix
  • Cyclopharm
  • Clarity Pharmaceuticals
  • Blue Earth Diagnostics
  • Progenics Pharmaceuticals
  • Navidea Biopharmaceuticals
  • Lantheus Holdings
  • Sofie Biosciences
  • Radiopharm Theranostics
  • Telix Pharmaceuticals
  • Cardinal Health Nuclear Pharmacy Services
簡介目錄
Product Code: GIS10340

Nuclear Medicine/Radiopharmaceuticals Market is anticipated to expand from $4.8 billion in 2024 to $12.6 billion by 2034, growing at a CAGR of approximately 10.1%. The market encompasses the production and application of radioactive substances for diagnosis and therapy. It involves imaging techniques like PET and SPECT, and therapeutic uses in oncology and cardiology. This market is driven by advancements in molecular imaging, increasing cancer prevalence, and a rising demand for non-invasive procedures, highlighting opportunities for innovation in targeted radiopharmaceuticals.

Market Overview

The Nuclear Medicine/Radiopharmaceuticals Market is characterized by a diverse array of segments, with diagnostic radiopharmaceuticals leading the charge, primarily due to their pivotal role in early disease detection and management. This segment's dominance is driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, coupled with advancements in imaging technologies like PET and SPECT. Therapeutic radiopharmaceuticals are rapidly gaining traction, particularly in oncology, where targeted radioisotope therapies offer promising treatment avenues with minimal side effects. Among emerging sub-segments, theranostics is poised to revolutionize the market by integrating diagnostic and therapeutic capabilities, providing personalized treatment strategies. Furthermore, the increasing application of radiopharmaceuticals in neurology, especially in Alzheimer's and Parkinson's disease research, underscores the potential for significant market impact. Continuous innovation in radioisotope production and regulatory support for novel radiopharmaceuticals further bolsters market growth, promising lucrative opportunities for stakeholders.

Market Segmentation
TypeDiagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals
ProductTechnetium-99m, Iodine-131, Fluorine-18, Lutetium-177, Yttrium-90, Gallium-68, Radium-223
ServicesRadioisotope Production, Radiopharmacy Services, Nuclear Imaging Services
TechnologySingle Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Hybrid Imaging
ApplicationOncology, Cardiology, Neurology, Endocrinology, Gastroenterology, Infectious Diseases, Nephrology
End UserHospitals, Diagnostic Imaging Centers, Academic and Research Institutes
FormLiquid, Capsule
Material TypeOrganic Compounds, Inorganic Compounds
ProcessCyclotron Production, Nuclear Reactor Production
EquipmentGamma Cameras, PET Scanners, SPECT Scanners

In the nuclear medicine and radiopharmaceuticals market, diagnostic radiopharmaceuticals hold a prominent share, driven by the increasing prevalence of chronic diseases and the rising demand for early and precise diagnostic techniques. Therapeutic radiopharmaceuticals are gaining traction as well, reflecting advancements in targeted cancer therapies and personalized medicine approaches. North America leads the market due to its robust healthcare infrastructure and significant research activities, while the Asia-Pacific region is witnessing rapid growth fueled by expanding healthcare investments and rising awareness of nuclear medicine applications.

The competitive landscape is marked by the presence of key players such as Siemens Healthineers, GE Healthcare, and Cardinal Health, which are actively engaged in strategic collaborations and technological innovations to enhance their market position. Regulatory environments, particularly in the United States and Europe, are becoming increasingly stringent, necessitating compliance with rigorous safety and efficacy standards. Looking ahead, the market is poised for substantial growth, driven by advancements in radiopharmaceutical production technologies and the expansion of nuclear medicine applications in oncology and cardiology. However, challenges such as high costs of development and regulatory approval processes remain, albeit with significant opportunities for growth arising from emerging markets and novel therapeutic applications.

Recent Developments:

The Nuclear Medicine/Radiopharmaceuticals Market has experienced noteworthy developments over the past three months. GE HealthCare announced a strategic partnership with NorthStar Medical Radioisotopes to advance the production of diagnostic and therapeutic radiopharmaceuticals, enhancing supply chain reliability and expanding product offerings. In a significant merger and acquisition move, Curium acquired IASON, a European leader in PET radiopharmaceuticals, to strengthen its position in the European market and broaden its product portfolio. Cardinal Health unveiled a new state-of-the-art radiopharmacy in the United States, aiming to improve the distribution efficiency of nuclear medicine products and meet the growing demand for radiopharmaceuticals. The European Medicines Agency approved a new radiopharmaceutical therapy developed by Telix Pharmaceuticals, marking a milestone for the company and expanding treatment options for prostate cancer. Lastly, Siemens Healthineers announced a collaboration with the University of Pennsylvania to develop innovative imaging technologies, focusing on enhancing the precision of nuclear medicine diagnostics. These developments underscore the sector's dynamic growth and the strategic maneuvers by key players to capitalize on emerging opportunities.

Key Trends and Drivers:

The nuclear medicine and radiopharmaceuticals market is experiencing robust growth, propelled by advancements in diagnostic imaging technologies and increasing prevalence of chronic diseases. Key trends include the integration of artificial intelligence in imaging solutions, enhancing diagnostic accuracy and efficiency. The development of novel radiopharmaceuticals targeting specific diseases is also gaining traction, offering personalized treatment options and improved patient outcomes.

Drivers of the market encompass the rising demand for non-invasive diagnostic techniques and the growing geriatric population, which is more susceptible to chronic conditions. Additionally, government initiatives promoting cancer research and nuclear medicine are bolstering market expansion. The increasing adoption of hybrid imaging systems, such as PET/CT and SPECT/CT, is further driving growth by providing comprehensive diagnostic insights.

Opportunities are emerging in untapped markets, particularly in developing regions where healthcare infrastructure is evolving. Companies investing in research and development to create innovative, cost-effective radiopharmaceuticals are well-positioned to capture market share. Furthermore, collaborations between academic institutions and industry players are fostering advancements in nuclear medicine, paving the way for future growth and innovation in the sector.

Restraints and Challenges:

The Nuclear Medicine/Radiopharmaceuticals Market encounters several significant restraints and challenges. Firstly, stringent regulatory requirements pose a substantial challenge. The approval process for new radiopharmaceuticals is complex and time-consuming, often delaying market entry. Additionally, high production costs for radiopharmaceuticals limit their accessibility and affordability, particularly in developing regions. Another challenge is the shortage of skilled professionals. The specialized knowledge required to handle and administer these substances is scarce, impacting service delivery. Furthermore, supply chain complexities, including the short half-life of radiopharmaceuticals, necessitate efficient logistics, which can be difficult to maintain. Lastly, public perception and safety concerns about radiation exposure hinder market acceptance, despite advancements in safety protocols. These challenges collectively impede the growth and broader adoption of nuclear medicine and radiopharmaceuticals.

Key Companies:

Advanced Accelerator Applications, Jubilant Radiopharma, Curium Pharma, North Star Medical Radioisotopes, Shine Medical Technologies, Isotopia Molecular Imaging, ITM Isotopen Technologien Munchen, Eckert & Ziegler, Nordion, Radio Medix, Cyclopharm, Clarity Pharmaceuticals, Blue Earth Diagnostics, Progenics Pharmaceuticals, Navidea Biopharmaceuticals, Lantheus Holdings, Sofie Biosciences, Radiopharm Theranostics, Telix Pharmaceuticals, Cardinal Health Nuclear Pharmacy Services

Sources:

World Nuclear Association, International Atomic Energy Agency (IAEA), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM), Radiological Society of North America (RSNA), American College of Radiology (ACR), National Institutes of Health (NIH), U.S. Department of Energy (DOE), Canadian Nuclear Safety Commission (CNSC), Australian Nuclear Science and Technology Organisation (ANSTO), Japan Atomic Energy Agency (JAEA), United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), International Conference on Radiopharmaceutical Sciences, World Congress of Nuclear Medicine and Biology, International Symposium on Radiopharmaceutical Chemistry, European Congress of Radiology, International Conference on Isotopes, International Atomic Energy Agency General Conference

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Nuclear Medicine/Radiopharmaceuticals Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Nuclear Medicine/Radiopharmaceuticals Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Form
  • 2.10 Key Highlights of the Market, by Material Type
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by Equipment
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Form
  • 3.9 Market Attractiveness Analysis, by Material Type
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by Equipment
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Nuclear Medicine/Radiopharmaceuticals Market Outlook

  • 4.1 Nuclear Medicine/Radiopharmaceuticals Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Nuclear Medicine/Radiopharmaceuticals Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Nuclear Medicine/Radiopharmaceuticals Market Size

  • 6.1 Nuclear Medicine/Radiopharmaceuticals Market Size, by Value
  • 6.2 Nuclear Medicine/Radiopharmaceuticals Market Size, by Volume

7: Nuclear Medicine/Radiopharmaceuticals Market, by Type

  • 7.1 Market Overview
  • 7.2 Diagnostic Radiopharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Radiopharmaceuticals
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Nuclear Medicine/Radiopharmaceuticals Market, by Product

  • 8.1 Market Overview
  • 8.2 Technetium-99m
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Iodine-131
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Fluorine-18
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Lutetium-177
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Yttrium-90
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Gallium-68
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Radium-223
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Nuclear Medicine/Radiopharmaceuticals Market, by Services

  • 9.1 Market Overview
  • 9.2 Radioisotope Production
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Radiopharmacy Services
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Nuclear Imaging Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Nuclear Medicine/Radiopharmaceuticals Market, by Technology

  • 10.1 Market Overview
  • 10.2 Single Photon Emission Computed Tomography (SPECT)
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Positron Emission Tomography (PET)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Hybrid Imaging
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Nuclear Medicine/Radiopharmaceuticals Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cardiology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Neurology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Endocrinology
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Gastroenterology
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Infectious Diseases
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Nephrology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Others
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region

12: Nuclear Medicine/Radiopharmaceuticals Market, by End User

  • 12.1 Market Overview
  • 12.2 Hospitals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Diagnostic Imaging Centers
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Academic and Research Institutes
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Nuclear Medicine/Radiopharmaceuticals Market, by Form

  • 13.1 Market Overview
  • 13.2 Liquid
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Capsule
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Nuclear Medicine/Radiopharmaceuticals Market, by Material Type

  • 14.1 Market Overview
  • 14.2 Organic Compounds
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Inorganic Compounds
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Nuclear Medicine/Radiopharmaceuticals Market, by Process

  • 15.1 Market Overview
  • 15.2 Cyclotron Production
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Nuclear Reactor Production
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Nuclear Medicine/Radiopharmaceuticals Market, by Equipment

  • 16.1 Market Overview
  • 16.2 Gamma Cameras
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 PET Scanners
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 SPECT Scanners
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Others
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region

17: Nuclear Medicine/Radiopharmaceuticals Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by End User
    • 17.2.8 North America Market Size and Forecast, by Form
    • 17.2.9 North America Market Size and Forecast, by Material Type
    • 17.2.10 North America Market Size and Forecast, by Process
    • 17.2.11 North America Market Size and Forecast, by Equipment
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by End User
      • 17.2.9.7 United States Market Size and Forecast, by Form
      • 17.2.9.8 United States Market Size and Forecast, by Material Type
      • 17.2.9.9 United States Market Size and Forecast, by Process
      • 17.2.9.10 United States Market Size and Forecast, by Equipment
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by End User
      • 17.2.10.7 Canada Market Size and Forecast, by Form
      • 17.2.10.8 Canada Market Size and Forecast, by Material Type
      • 17.2.10.9 Canada Market Size and Forecast, by Process
      • 17.2.10.10 Canada Market Size and Forecast, by Equipment
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by End User
    • 17.3.8 Europe Market Size and Forecast, by Form
    • 17.3.9 Europe Market Size and Forecast, by Material Type
    • 17.3.10 Europe Market Size and Forecast, by Process
    • 17.3.11 Europe Market Size and Forecast, by Equipment
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Material Type
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Equipment
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by End User
      • 17.3.10.7 Germany Market Size and Forecast, by Form
      • 17.3.10.8 Germany Market Size and Forecast, by Material Type
      • 17.3.10.9 Germany Market Size and Forecast, by Process
      • 17.3.10.10 Germany Market Size and Forecast, by Equipment
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by End User
      • 17.3.11.7 France Market Size and Forecast, by Form
      • 17.3.11.8 France Market Size and Forecast, by Material Type
      • 17.3.11.9 France Market Size and Forecast, by Process
      • 17.3.11.10 France Market Size and Forecast, by Equipment
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by End User
      • 17.3.12.7 Spain Market Size and Forecast, by Form
      • 17.3.12.8 Spain Market Size and Forecast, by Material Type
      • 17.3.12.9 Spain Market Size and Forecast, by Process
      • 17.3.12.10 Spain Market Size and Forecast, by Equipment
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by End User
      • 17.3.13.7 Italy Market Size and Forecast, by Form
      • 17.3.13.8 Italy Market Size and Forecast, by Material Type
      • 17.3.13.9 Italy Market Size and Forecast, by Process
      • 17.3.13.10 Italy Market Size and Forecast, by Equipment
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by End User
      • 17.3.14.7 Netherlands Market Size and Forecast, by Form
      • 17.3.14.8 Netherlands Market Size and Forecast, by Material Type
      • 17.3.14.9 Netherlands Market Size and Forecast, by Process
      • 17.3.14.10 Netherlands Market Size and Forecast, by Equipment
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by End User
      • 17.3.15.7 Sweden Market Size and Forecast, by Form
      • 17.3.15.8 Sweden Market Size and Forecast, by Material Type
      • 17.3.15.9 Sweden Market Size and Forecast, by Process
      • 17.3.15.10 Sweden Market Size and Forecast, by Equipment
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by End User
      • 17.3.16.7 Switzerland Market Size and Forecast, by Form
      • 17.3.16.8 Switzerland Market Size and Forecast, by Material Type
      • 17.3.16.9 Switzerland Market Size and Forecast, by Process
      • 17.3.16.10 Switzerland Market Size and Forecast, by Equipment
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by End User
      • 17.3.17.7 Denmark Market Size and Forecast, by Form
      • 17.3.17.8 Denmark Market Size and Forecast, by Material Type
      • 17.3.17.9 Denmark Market Size and Forecast, by Process
      • 17.3.17.10 Denmark Market Size and Forecast, by Equipment
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by End User
      • 17.3.18.7 Finland Market Size and Forecast, by Form
      • 17.3.18.8 Finland Market Size and Forecast, by Material Type
      • 17.3.18.9 Finland Market Size and Forecast, by Process
      • 17.3.18.10 Finland Market Size and Forecast, by Equipment
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by End User
      • 17.3.19.7 Russia Market Size and Forecast, by Form
      • 17.3.19.8 Russia Market Size and Forecast, by Material Type
      • 17.3.19.9 Russia Market Size and Forecast, by Process
      • 17.3.19.10 Russia Market Size and Forecast, by Equipment
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Material Type
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Equipment
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Material Type
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Equipment
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by End User
      • 17.4.9.7 China Market Size and Forecast, by Form
      • 17.4.9.8 China Market Size and Forecast, by Material Type
      • 17.4.9.9 China Market Size and Forecast, by Process
      • 17.4.9.10 China Market Size and Forecast, by Equipment
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by End User
      • 17.4.10.7 India Market Size and Forecast, by Form
      • 17.4.10.8 India Market Size and Forecast, by Material Type
      • 17.4.10.9 India Market Size and Forecast, by Process
      • 17.4.10.10 India Market Size and Forecast, by Equipment
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by End User
      • 17.4.11.7 Japan Market Size and Forecast, by Form
      • 17.4.11.8 Japan Market Size and Forecast, by Material Type
      • 17.4.11.9 Japan Market Size and Forecast, by Process
      • 17.4.11.10 Japan Market Size and Forecast, by Equipment
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by End User
      • 17.4.12.7 South Korea Market Size and Forecast, by Form
      • 17.4.12.8 South Korea Market Size and Forecast, by Material Type
      • 17.4.12.9 South Korea Market Size and Forecast, by Process
      • 17.4.12.10 South Korea Market Size and Forecast, by Equipment
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by End User
      • 17.4.13.7 Australia Market Size and Forecast, by Form
      • 17.4.13.8 Australia Market Size and Forecast, by Material Type
      • 17.4.13.9 Australia Market Size and Forecast, by Process
      • 17.4.13.10 Australia Market Size and Forecast, by Equipment
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by End User
      • 17.4.14.7 Singapore Market Size and Forecast, by Form
      • 17.4.14.8 Singapore Market Size and Forecast, by Material Type
      • 17.4.14.9 Singapore Market Size and Forecast, by Process
      • 17.4.14.10 Singapore Market Size and Forecast, by Equipment
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by End User
      • 17.4.15.7 Indonesia Market Size and Forecast, by Form
      • 17.4.15.8 Indonesia Market Size and Forecast, by Material Type
      • 17.4.15.9 Indonesia Market Size and Forecast, by Process
      • 17.4.15.10 Indonesia Market Size and Forecast, by Equipment
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by End User
      • 17.4.16.7 Taiwan Market Size and Forecast, by Form
      • 17.4.16.8 Taiwan Market Size and Forecast, by Material Type
      • 17.4.16.9 Taiwan Market Size and Forecast, by Process
      • 17.4.16.10 Taiwan Market Size and Forecast, by Equipment
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by End User
      • 17.4.17.7 Malaysia Market Size and Forecast, by Form
      • 17.4.17.8 Malaysia Market Size and Forecast, by Material Type
      • 17.4.17.9 Malaysia Market Size and Forecast, by Process
      • 17.4.17.10 Malaysia Market Size and Forecast, by Equipment
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Material Type
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Equipment
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by End User
    • 17.5.8 Latin America Market Size and Forecast, by Form
    • 17.5.9 Latin America Market Size and Forecast, by Material Type
    • 17.5.10 Latin America Market Size and Forecast, by Process
    • 17.5.11 Latin America Market Size and Forecast, by Equipment
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by End User
      • 17.5.9.7 Brazil Market Size and Forecast, by Form
      • 17.5.9.8 Brazil Market Size and Forecast, by Material Type
      • 17.5.9.9 Brazil Market Size and Forecast, by Process
      • 17.5.9.10 Brazil Market Size and Forecast, by Equipment
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by End User
      • 17.5.10.7 Mexico Market Size and Forecast, by Form
      • 17.5.10.8 Mexico Market Size and Forecast, by Material Type
      • 17.5.10.9 Mexico Market Size and Forecast, by Process
      • 17.5.10.10 Mexico Market Size and Forecast, by Equipment
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by End User
      • 17.5.11.7 Argentina Market Size and Forecast, by Form
      • 17.5.11.8 Argentina Market Size and Forecast, by Material Type
      • 17.5.11.9 Argentina Market Size and Forecast, by Process
      • 17.5.11.10 Argentina Market Size and Forecast, by Equipment
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Material Type
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Equipment
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Material Type
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Equipment
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Material Type
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Equipment
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by End User
      • 17.6.10.7 UAE Market Size and Forecast, by Form
      • 17.6.10.8 UAE Market Size and Forecast, by Material Type
      • 17.6.10.9 UAE Market Size and Forecast, by Process
      • 17.6.10.10 UAE Market Size and Forecast, by Equipment
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by End User
      • 17.6.11.7 South Africa Market Size and Forecast, by Form
      • 17.6.11.8 South Africa Market Size and Forecast, by Material Type
      • 17.6.11.9 South Africa Market Size and Forecast, by Process
      • 17.6.11.10 South Africa Market Size and Forecast, by Equipment
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Material Type
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Equipment
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Advanced Accelerator Applications
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Jubilant Radiopharma
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Curium Pharma
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 NorthStar Medical Radioisotopes
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Shine Medical Technologies
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Isotopia Molecular Imaging
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 ITM Isotopen Technologien Munchen
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Eckert & Ziegler
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Nordion
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 RadioMedix
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Cyclopharm
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Clarity Pharmaceuticals
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Blue Earth Diagnostics
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Progenics Pharmaceuticals
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Navidea Biopharmaceuticals
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Lantheus Holdings
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Sofie Biosciences
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Radiopharm Theranostics
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Telix Pharmaceuticals
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Cardinal Health Nuclear Pharmacy Services
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis